-
公开(公告)号:US20210169865A1
公开(公告)日:2021-06-10
申请号:US17178609
申请日:2021-02-18
发明人: Mark Merchant , Deepak Sampath , Marina Konopleva , Lina Han
IPC分类号: A61K31/4523 , A61K45/06 , A61K31/496 , A61P35/02
摘要: The present invention is directed to a combination therapy involving a selective Bcl-2 inhibitor and a MEK inhibitor for the treatment of a patient in need of such a therapy. The patient in need of the combination therapy is suffering from cancer, such as acute myeloid leukemia.
-
公开(公告)号:US20180303815A1
公开(公告)日:2018-10-25
申请号:US15767914
申请日:2016-11-03
发明人: Mark Merchant , Deepak Sampath , Marina Konopleva , Lina Han
IPC分类号: A61K31/4523 , A61P35/02
CPC分类号: A61K31/4523 , A61K31/496 , A61K45/06 , A61K2300/00 , A61P35/02
摘要: The present invention is directed to a combination therapy involving a selective Bcl-2 inhibitor and a MEK inhibitor for the treatment of a patient in need of such a therapy. The patient in need of the combination therapy is suffering from cancer, such as acute myeloid leukemia.
-
公开(公告)号:US10959993B2
公开(公告)日:2021-03-30
申请号:US15767914
申请日:2016-11-03
发明人: Mark Merchant , Deepak Sampath , Marina Konopleva , Lina Han
IPC分类号: A61K31/5365 , A61K31/497 , A61K31/4523 , A61K45/06 , A61K31/496 , A61P35/02
摘要: The present invention is directed to a combination therapy involving a selective Bcl-2 inhibitor and a MEK inhibitor for the treatment of a patient in need of such a therapy. The patient in need of the combination therapy is suffering from cancer, such as acute myeloid leukemia.
-
-